Gilead Sciences, Inc (GILD) insider trading
Every open-market stock purchase and sale by Gilead Sciences, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Healthcare.
Insider activity at a glance
- Daniel Patrick O'Day (CEO) and 4 others sold $15.9M in the last 90 days.
- Last insider buy: Olsen Per Wold (Director), $999K, 11 years ago.
- Congress: Jared Moskowitz bought $1K to $15K, 6 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $87.9M (44 sales). Last close $153.57 on Oct 21, 2026.
Recent GILD insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 15, 2026 | Johanna Mercier (Officer) | Sold | $469K |
| Oct 15, 2026 | Andrew D Dickinson (CFO) | Sold | $469K |
| Oct 1, 2026 | Daniel Patrick O'Day (CEO) | Sold | $1.8M |
| Oct 1, 2026 | Daniel Patrick O'Day (CEO) | Sold | $446K |
| Sep 22, 2026 | Erin Burkhart (VP) | Sold (not open market) | $117K |
| Sep 22, 2026 | Erin Burkhart (VP) | Bought (not open market) | — |
| Sep 15, 2026 | Andrew D Dickinson (CFO) | Sold | $436K |
| Sep 15, 2026 | Johanna Mercier (Officer) | Sold | $230K |
| Sep 15, 2026 | Johanna Mercier (Officer) | Sold | $116K |
| Sep 15, 2026 | Johanna Mercier (Officer) | Sold | $87.2K |
| Sep 10, 2026 | Daniel Patrick O'Day (CEO) | Sold (not open market) | $613K |
| Sep 10, 2026 | Andrew D Dickinson (CFO) | Sold (not open market) | $195K |
| Sep 10, 2026 | Johanna Mercier (Officer) | Sold (not open market) | $195K |
| Sep 10, 2026 | Wettan Keeley M Cain (VP) | Sold (not open market) | $41.3K |
| Sep 10, 2026 | Dietmar Berger (C-suite exec) | Sold (not open market) | $38.1K |
| Sep 10, 2026 | Dietmar Berger (C-suite exec) | Bought (not open market) | — |
| Sep 10, 2026 | Johanna Mercier (Officer) | Bought (not open market) | — |
| Sep 10, 2026 | Daniel Patrick O'Day (CEO) | Bought (not open market) | — |
| Sep 10, 2026 | Wettan Keeley M Cain (VP) | Bought (not open market) | — |
| Sep 10, 2026 | Andrew D Dickinson (CFO) | Bought (not open market) | — |
| Sep 1, 2026 | Daniel Patrick O'Day (CEO) | Sold | $1.2M |
| Sep 1, 2026 | Daniel Patrick O'Day (CEO) | Sold | $808K |
| Sep 1, 2026 | Daniel Patrick O'Day (CEO) | Sold | $236K |
| Aug 26, 2026 | Anthony Welters (Director) | Sold | $1M |
| Aug 26, 2026 | Anthony Welters (Director) | Sold | $685K |
Who's trading GILD
- Andrew D Dickinson, CFO: sold $4.9M (12 sales), last Oct 15, 2026
- Johanna Mercier, C-suite exec: sold $18.6M (23 sales), last Oct 15, 2026
- Daniel Patrick O'Day, CEO: sold $52.4M (28 sales), last Oct 1, 2026
- Erin Burkhart, VP: other filings, last Sep 22, 2026
- Dietmar Berger, C-suite exec: other filings, last Sep 10, 2026
- Wettan Keeley M Cain, VP: other filings, last Sep 10, 2026
- Anthony Welters, Director: sold $2.7M (4 sales), last Aug 26, 2026
- Jeffrey Bluestone, Director: sold $2M (7 sales), last Aug 20, 2026
- Jared Moskowitz, Representative: bought $8K (1 buy), last May 6, 2026
- Ted W Love, Director: other filings, last Apr 30, 2026
- Jacqueline K Barton, Director: other filings, last Apr 30, 2026
- Javier Rodriguez, Director: other filings, last Apr 30, 2026
- Sandra Horning, Director: other filings, last Apr 30, 2026
- Kelly A. Kramer, Director: sold $713K (2 sales), last Apr 30, 2026
- Harish Manwani, Director: other filings, last Apr 30, 2026
Get free alerts when an insider at Gilead Sciences, Inc files a new trade →